Trial intelligence / Profile preview

High-dose intraoperative remifentanil with or without amantadine in major abdominal surgery

DRKS00004626Phase 4Completed

Sponsor
Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin, Campus Charite Mitte und Virchow Klinikum, Charite - Universitätsmedizin Berlin Univ.-Prof. Dr. med. Michael Schäfer Augustenburger Platz 1
Start
Apr 2013
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remifentanil and amantadine in postoperative pain (3 arms), sponsored by Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin, Campus Charite Mitte und Virchow Klinikum, Charite - Universitätsmedizin Berlin Univ.-Prof. Dr. med. Michael Schäfer Augustenburger Platz 1. Primary endpoints: Postoperative pain intensity and Postoperative morphine consumption. Started Apr 2013; status: completed.

02

Drugs

remifentanilamantadine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on DRKS00004626.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00004626.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call